Current Trends in the Management of Diabetic Retinopathy: A Narrative Review
International Journal of Drug Delivery Technology · 30.04.2026 · 16 (41s)
DOI: 10.25258/ijddt.16.41s.19 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 30.04.2026. Verfasst von Kamya Kashyap und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Diabetic Retinopathy remains a leading cause of preventable vision loss among working-age adults worldwide,paralleling the increasing global prevalence of diabetes mellitus. Early detection and timely intervention arecritical, as the disease often remains asymptomatic until advanced stages. This narrative review aims tosynthesize current trends in the management of diabetic retinopathy, with a focus on screening strategies,classification and staging, comparative effectiveness of laser versus anti-vascular endothelial growth factor(anti-VEGF) therapy, and recent therapeutic advances. A comprehensive literature search was conducted usingPubMed, Scopus, and Google Scholar, including studies published over the past 10–15 years such as clinicalguidelines, randomized controlled trials, and review articles. Advances in retinal imaging and screeningmodalities—including teleophthalmology and artificial intelligence-based systems—have significantlyimproved early detection and disease monitoring. The understanding of disease pathophysiology, particularlythe role of Vascular Endothelial Growth Factor, has led to the widespread adoption of anti-VEGF therapy as thefirst-line treatment for diabetic macular edema and an important option for proliferative diabetic retinopathy.While anti-VEGF therapy demonstrates superior visual outcomes, particularly in diabetic macular edema, laserphotocoagulation continues to play a crucial role due to its durability, cost-effectiveness, and accessibility,especially in resource-limited settings. Emerging approaches, including intravitreal corticosteroids, long-actingdrug delivery systems, and gene therapy, offer promising avenues for reducing treatment burden and improvinglong-term outcomes. In conclusion, the management of diabetic retinopathy is evolving toward a moreintegrated and individualized approach that combines early screening, precise staging, and tailored therapeuticstrategies. Addressing challenges related to accessibility, cost, and patient adherence will be essential totranslate these advances into meaningful reductions in global vision loss.
Zitieren
APA
Kashyap, K., & Pandey, M. L. (2026). Current Trends in the Management of Diabetic Retinopathy: A Narrative Review. International Journal of Drug Delivery Technology, 16(41s). https://doi.org/10.25258/ijddt.16.41s.19
Vancouver
Kashyap K, Pandey ML. Current Trends in the Management of Diabetic Retinopathy: A Narrative Review. International Journal of Drug Delivery Technology. 2026;16(41s). doi:10.25258/ijddt.16.41s.19
BibTeX
@article{Kashyap2026,
author = {Kashyap, Kamya and Pandey, Mohan Lal},
title = {Current Trends in the Management of Diabetic Retinopathy: A Narrative Review},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {41s},
doi = {10.25258/ijddt.16.41s.19}
}
EUVIMED